American Portfolios Advisors’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$4.92K Hold
143
﹤0.01% 2826
2022
Q2
$4.61K Hold
143
﹤0.01% 2853
2022
Q1
$5.66K Hold
143
﹤0.01% 2902
2021
Q4
$6.76K Hold
143
﹤0.01% 2787
2021
Q3
$7.81K Buy
+143
New +$8.09K ﹤0.01% 2673
2019
Q3
Sell
-1,480
Closed -$50.5K 2913
2019
Q2
$50.5K Hold
1,480
﹤0.01% 1270
2019
Q1
$51.5K Buy
+1,480
New +$49.1K ﹤0.01% 1180

Other funds holding BTEC

American Portfolios Advisors's BTEC Position: Q3 2022 in Review

American Portfolios Advisors held its Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) position steady in Q3 2022 at 143 shares worth $4.92K. The position accounts for ﹤0.01% of the portfolio, ranked #2826.

American Portfolios Advisors first reported a position in BTEC in Q1 2019 and has held it in 7 quarters since. The position peaked at $51.5K in Q1 2019. 27 funds tracked by Wall St. Rank hold BTEC as of Q3 2022.

  • American Portfolios Advisors held 143 shares of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF worth $4.92K as of Q3 2022.
  • American Portfolios Advisors left its Principal Exchange-Traded Funds Principal Healthcare Innovators ETF share count unchanged in Q3 2022.
  • Principal Exchange-Traded Funds Principal Healthcare Innovators ETF made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2826 holding.
  • American Portfolios Advisors first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q1 2019 and has held it in 7 quarters since.
  • American Portfolios Advisors's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $51.5K in Q1 2019.
  • 27 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.